FDAnews
www.fdanews.com/articles/122958-basilea-8217-s-toctino-recommended-for-approval-in-15-additional-european-countries

Basilea’s Toctino Recommended for Approval in 15 Additional European Countries

December 14, 2009
Basilea Pharmaceutica Ltd. announces that Toctino (alitretinoin) was recommended for regulatory approval under the Repeat-use Procedure in 13 additional European Union Member States as well as in Norway and Iceland.
CNNMoney